Global Pandemic Influenza Vaccine Market Insights and Forecast to 2026

Global Pandemic Influenza Vaccine Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pandemic Influenza Vaccine Product Introduction
1.2 Market Segments
1.3 Key Pandemic Influenza Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Type
1.4.2 Influenza A (H1N1) Vaccines
1.4.3 Other
1.5 Market by Application
1.5.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Application
1.5.2 Adult
1.5.3 Paediatric
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pandemic Influenza Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Pandemic Influenza Vaccine Revenue 2015-2026
2.1.2 Global Pandemic Influenza Vaccine Sales 2015-2026
2.2 Global Pandemic Influenza Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pandemic Influenza Vaccine Competitor Landscape by Players
3.1 Pandemic Influenza Vaccine Sales by Manufacturers
3.1.1 Pandemic Influenza Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Pandemic Influenza Vaccine Revenue by Manufacturers
3.2.1 Pandemic Influenza Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Pandemic Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pandemic Influenza Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pandemic Influenza Vaccine Revenue in 2019
3.2.5 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pandemic Influenza Vaccine Price by Manufacturers
3.4 Pandemic Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pandemic Influenza Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pandemic Influenza Vaccine Market Size by Type (2015-2020)
4.1.1 Global Pandemic Influenza Vaccine Sales by Type (2015-2020)
4.1.2 Global Pandemic Influenza Vaccine Revenue by Type (2015-2020)
4.1.3 Pandemic Influenza Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pandemic Influenza Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Pandemic Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pandemic Influenza Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pandemic Influenza Vaccine Market Size by Application (2015-2020)
5.1.1 Global Pandemic Influenza Vaccine Sales by Application (2015-2020)
5.1.2 Global Pandemic Influenza Vaccine Revenue by Application (2015-2020)
5.1.3 Pandemic Influenza Vaccine Price by Application (2015-2020)
5.2 Pandemic Influenza Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pandemic Influenza Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pandemic Influenza Vaccine by Country
6.1.1 North America Pandemic Influenza Vaccine Sales by Country
6.1.2 North America Pandemic Influenza Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pandemic Influenza Vaccine Market Facts & Figures by Type
6.3 North America Pandemic Influenza Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Pandemic Influenza Vaccine by Country
7.1.1 Europe Pandemic Influenza Vaccine Sales by Country
7.1.2 Europe Pandemic Influenza Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pandemic Influenza Vaccine Market Facts & Figures by Type
7.3 Europe Pandemic Influenza Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pandemic Influenza Vaccine by Region
8.1.1 Asia Pacific Pandemic Influenza Vaccine Sales by Region
8.1.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pandemic Influenza Vaccine by Country
9.1.1 Latin America Pandemic Influenza Vaccine Sales by Country
9.1.2 Latin America Pandemic Influenza Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pandemic Influenza Vaccine Market Facts & Figures by Type
9.3 Central & South America Pandemic Influenza Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pandemic Influenza Vaccine by Country
10.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Country
10.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
11.1.5 AstraZeneca Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Pandemic Influenza Vaccine Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description and Business Overview
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Pandemic Influenza Vaccine Products Offered
11.3.5 Novartis Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Pandemic Influenza Vaccine Products Offered
11.4.5 Sanofi Related Developments
11.5 Valneva
11.5.1 Valneva Corporation Information
11.5.2 Valneva Description and Business Overview
11.5.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Valneva Pandemic Influenza Vaccine Products Offered
11.5.5 Valneva Related Developments
11.6 Lupin
11.6.1 Lupin Corporation Information
11.6.2 Lupin Description and Business Overview
11.6.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Lupin Pandemic Influenza Vaccine Products Offered
11.6.5 Lupin Related Developments
11.7 Chiron Panacea
11.7.1 Chiron Panacea Corporation Information
11.7.2 Chiron Panacea Description and Business Overview
11.7.3 Chiron Panacea Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Chiron Panacea Pandemic Influenza Vaccine Products Offered
11.7.5 Chiron Panacea Related Developments
11.8 Solvay and Serum Institute of India Pvt. Ltd.
11.8.1 Solvay and Serum Institute of India Pvt. Ltd. Corporation Information
11.8.2 Solvay and Serum Institute of India Pvt. Ltd. Description and Business Overview
11.8.3 Solvay and Serum Institute of India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Products Offered
11.8.5 Solvay and Serum Institute of India Pvt. Ltd. Related Developments
11.9 Sementis
11.9.1 Sementis Corporation Information
11.9.2 Sementis Description and Business Overview
11.9.3 Sementis Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sementis Pandemic Influenza Vaccine Products Offered
11.9.5 Sementis Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
11.1.5 AstraZeneca Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pandemic Influenza Vaccine Market Estimates and Projections by Region
12.1.1 Global Pandemic Influenza Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Pandemic Influenza Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pandemic Influenza Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pandemic Influenza Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pandemic Influenza Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Pandemic Influenza Vaccine Market Segments
Table 2. Ranking of Global Top Pandemic Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pandemic Influenza Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Influenza A (H1N1) Vaccines
Table 5. Major Manufacturers of Other
Table 6. Global Pandemic Influenza Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 7. Global Pandemic Influenza Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 8. Global Pandemic Influenza Vaccine Sales by Regions 2015-2020 (K Doses)
Table 9. Global Pandemic Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 10. Global Pandemic Influenza Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Pandemic Influenza Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 12. Global Pandemic Influenza Vaccine Sales Share by Manufacturers (2015-2020)
Table 13. Global Pandemic Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pandemic Influenza Vaccine as of 2019)
Table 15. Pandemic Influenza Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Pandemic Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Pandemic Influenza Vaccine Price (2015-2020) (USD/Dose)
Table 18. Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Pandemic Influenza Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 23. Global Pandemic Influenza Vaccine Sales Share by Type (2015-2020)
Table 24. Global Pandemic Influenza Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Pandemic Influenza Vaccine Revenue Share by Type (2015-2020)
Table 26. Pandemic Influenza Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 27. Global Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 28. Global Pandemic Influenza Vaccine Sales Share by Application (2015-2020)
Table 29. North America Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 30. North America Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 31. North America Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 33. North America Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 34. North America Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 35. North America Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 36. North America Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 37. Europe Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 38. Europe Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 39. Europe Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 41. Europe Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 42. Europe Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 43. Europe Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 44. Europe Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Pandemic Influenza Vaccine Sales by Region (2015-2020) (K Doses)
Table 46. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 50. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 52. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 53. Latin America Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 54. Latin America Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 57. Latin America Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 58. Latin America Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 59. Latin America Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 60. Latin America Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 62. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 66. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 68. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 69. AstraZeneca Corporation Information
Table 70. AstraZeneca Description and Major Businesses
Table 71. AstraZeneca Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 72. AstraZeneca Product
Table 73. AstraZeneca Recent Development
Table 74. GlaxoSmithKline Corporation Information
Table 75. GlaxoSmithKline Description and Major Businesses
Table 76. GlaxoSmithKline Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Recent Development
Table 79. Novartis Corporation Information
Table 80. Novartis Description and Major Businesses
Table 81. Novartis Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Novartis Product
Table 83. Novartis Recent Development
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Major Businesses
Table 86. Sanofi Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Sanofi Product
Table 88. Sanofi Recent Development
Table 89. Valneva Corporation Information
Table 90. Valneva Description and Major Businesses
Table 91. Valneva Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. Valneva Product
Table 93. Valneva Recent Development
Table 94. Lupin Corporation Information
Table 95. Lupin Description and Major Businesses
Table 96. Lupin Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Lupin Product
Table 98. Lupin Recent Development
Table 99. Chiron Panacea Corporation Information
Table 100. Chiron Panacea Description and Major Businesses
Table 101. Chiron Panacea Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Chiron Panacea Product
Table 103. Chiron Panacea Recent Development
Table 104. Solvay and Serum Institute of India Pvt. Ltd. Corporation Information
Table 105. Solvay and Serum Institute of India Pvt. Ltd. Description and Major Businesses
Table 106. Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Solvay and Serum Institute of India Pvt. Ltd. Product
Table 108. Solvay and Serum Institute of India Pvt. Ltd. Recent Development
Table 109. Sementis Corporation Information
Table 110. Sementis Description and Major Businesses
Table 111. Sementis Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Sementis Product
Table 113. Sementis Recent Development
Table 114. Global Pandemic Influenza Vaccine Sales Forecast by Regions (2021-2026) (K Doses)
Table 115. Global Pandemic Influenza Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Pandemic Influenza Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Pandemic Influenza Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 119. North America: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 121. Europe: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Pandemic Influenza Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 123. Asia Pacific: Pandemic Influenza Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 125. Latin America: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 127. Middle East and Africa: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Pandemic Influenza Vaccine Players
Table 132. Pandemic Influenza Vaccine Customers List
Table 133. Pandemic Influenza Vaccine Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Pandemic Influenza Vaccine Product Picture
Figure 2. Global Pandemic Influenza Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Influenza A (H1N1) Vaccines Product Picture
Figure 4. Other Product Picture
Figure 5. Global Pandemic Influenza Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Adult
Figure 7. Paediatric
Figure 8. Pandemic Influenza Vaccine Report Years Considered
Figure 9. Global Pandemic Influenza Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Pandemic Influenza Vaccine Sales 2015-2026 (K Doses)
Figure 11. Global Pandemic Influenza Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Pandemic Influenza Vaccine Sales Market Share by Region (2015-2020)
Figure 13. Global Pandemic Influenza Vaccine Sales Market Share by Region in 2019
Figure 14. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2015-2020)
Figure 15. Global Pandemic Influenza Vaccine Revenue Market Share by Region in 2019
Figure 16. Global Pandemic Influenza Vaccine Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Pandemic Influenza Vaccine Revenue in 2019
Figure 18. Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Figure 20. Global Pandemic Influenza Vaccine Sales Market Share by Type in 2019
Figure 21. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2015-2020)
Figure 22. Global Pandemic Influenza Vaccine Revenue Market Share by Type in 2019
Figure 23. Global Pandemic Influenza Vaccine Market Share by Price Range (2015-2020)
Figure 24. Global Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Figure 25. Global Pandemic Influenza Vaccine Sales Market Share by Application in 2019
Figure 26. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2015-2020)
Figure 27. Global Pandemic Influenza Vaccine Revenue Market Share by Application in 2019
Figure 28. North America Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 29. North America Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 31. North America Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 32. U.S. Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 33. U.S. Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 35. Canada Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 37. North America Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 38. Europe Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 39. Europe Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 41. Europe Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 42. Germany Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Germany Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 45. France Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 47. U.K. Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Italy Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Russia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 53. Europe Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 54. Asia Pacific Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 55. Asia Pacific Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region in 2019
Figure 57. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Region in 2019
Figure 58. China Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 59. China Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Japan Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 63. South Korea Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 65. India Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Australia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Taiwan Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Indonesia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Thailand Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Malaysia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Philippines Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Vietnam Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 81. Asia Pacific Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 82. Latin America Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 83. Latin America Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 85. Latin America Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 86. Mexico Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 87. Mexico Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Brazil Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Argentina Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 93. Latin America Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 94. Middle East and Africa Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 95. Middle East and Africa Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 98. Turkey Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 99. Turkey Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Saudi Arabia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 103. U.A.E Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 105. Middle East and Africa Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 106. North America Pandemic Influenza Vaccine S

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs